| Short Description : | Recombinant-Active-Human ACVR2A/ACTR-IIA-C-His protein was developed from mammalian cells and has a target region of C-His. For use in research applications. |
| Applications: | ELISA/WB |
| Host: | Mammalian Cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Dilution Range: | Reconstitute in sterile water for a stock solution. |
| Formulation: | Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol. |
| Storage Instruction: | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at-20 to-80°C for twelve months from the date of receipt. |
| Endotoxin: | <0.1 EU/Mu g of the protein by the LAL method. |
| Immunoreactivity: | Measured by its ability to inhibit Activin A-induced hemoglobin expression in human chronic myelogenous leukemia cells (K562). Approximately 0.01-0.05 Mu g/mL of recombinant human ACVR2A/ACTR-IIA will inhibit 50% of the biological response due to 3 n |
| Gene Symbol: | ACVR2A |
| Gene ID: | 92 |
| Uniprot ID: | AVR2A_HUMAN |
| Immunogen: | Homo sapiens (Human) |
| Immunogen Region: | Ala20-Pro134 |
Information sourced from Uniprot.org
